Quarterly Updates29 May 2026, 03:59 pm
3B BlackBio Dx: FY26 Revenue ₹97.27 Cr, Up YoY
AI Summary
3B BlackBio Dx Ltd announced audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board recommended a final dividend of 50% (₹5.00 per share). Revenue from operations for FY26 stood at ₹9727.50 Lakhs compared to ₹9052.97 Lakhs in FY25. The Board also approved the appointment of M/s Ali Jain & Sharma as Internal Auditors for FY27.
Key Highlights
- 3B BlackBio Dx FY26 revenue from operations increased to ₹97.27 Cr from ₹90.53 Cr YoY.
- The Board recommended a final dividend of ₹5.00 per equity share.
- Net profit for FY26 stood at ₹4931.69 Lakhs.
- M/s Ali Jain & Sharma appointed as Internal Auditors for FY27.
Price Impact
More from KILPEST